SCHEMBL6957230

SCHEMBL6957230

CC1CCCC(c2nc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
PTGS2 P35354 14/20 0.40
PTGS1 P23219 10/20 0.40
PDPK1 O15530 6/20 0.40
CYP2C9 P11712 2/20 0.40
PTGES O14684 1/20 0.40
HDAC3 O15379 1/20 0.40
CA12 O43570 1/20 0.40
PDE5A O76074 1/20 0.40
ABCB11 O95342 1/20 0.40
MT-CO2 P00403 1/20 0.40
LMNA P02545 1/20 0.40
CA3 P07451 1/20 0.40
CYP3A4 P08684 1/20 0.40
ALOX5 P09917 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
CYP2D6 P10635 1/20 0.40
ADRB3 P13945 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6969710 0.90 PTGS2 (0.44) CA1CA2PTGS2PTGS1PDPK1
SCHEMBL6959431 0.88 CA1 (0.47) CA1CA2PTGS2PTGS1PDPK1
SCHEMBL6962612 0.87 PTGS2 (0.40) CA1CA2PTGS2PTGS1PDPK1
SCHEMBL5865496 0.87 CA1 (0.48) CA1CA2PTGS2PTGS1PDPK1
SCHEMBL6957521 0.81 PDPK1 (0.42) CA1CA2PTGS2PTGS1PDPK1
SCHEMBL6967100 0.81 PTGS2 (0.43) CA1CA2PTGS2PTGS1PDPK1
SCHEMBL5865483 0.78 CYP1A2 (0.50) PTGS2PTGS1CYP2C9CYP2D6
SCHEMBL6956674 0.77 PTGS2 (0.39) CA1CA2PTGS2PTGS1PDPK1
SCHEMBL6958188 0.77 PTGS2 (0.41) CA1CA2PTGS2PTGS1PDPK1
SCHEMBL5865451 0.76 PTGS2 (0.42) CA1CA2PTGS2PTGS1PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030125368-A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents SAKYA SUBAS M (US) 2003-07-03 US claimed
EP-1273576-A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents Pfizer Products Inc. (US) 2003-01-08 EP claimed
US-20030125368-A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents SAKYA SUBAS M (US) 2003-07-03 US disclosed
EP-1273576-A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents Pfizer Products Inc. (US) 2003-01-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030125368-A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents SULT2A1, AHR, SULT1A1 CA1 493/4885CA2 1358/4885PTGS2 287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.